Ascendis Pharma A/S ADR (NASDAQ: ASND) kicked off on Monday, up 5.95% from the previous trading day, before settling in for the closing price of $204.4. Over the past 52 weeks, ASND has traded in a range of $118.03-$219.30.
Annual sales at Healthcare sector company slipped by -6.13% over the past five years. While this was happening, its average annual earnings per share was recorded 49.98%. With a float of $60.68 million, this company’s outstanding shares have now reached $61.10 million.
Ascendis Pharma A/S ADR (ASND) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ascendis Pharma A/S ADR is 0.68%, while institutional ownership is 104.75%. The most recent insider transaction that took place on Sep 09 ’25, was worth 1,018,503. Before that another transaction happened on Aug 29 ’25, when Company’s Officer proposed sale 5,000 for $193.00, making the entire transaction worth $965,000.
Ascendis Pharma A/S ADR (ASND) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.64 earnings per share (EPS), higher than consensus estimate (set at -0.93) by 0.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.41 per share during the current fiscal year.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Trading Performance Indicators
Take a look at Ascendis Pharma A/S ADR’s (ASND) current performance indicators. Last quarter, stock had a quick ratio of 0.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.25, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 3.98 in one year’s time.
Technical Analysis of Ascendis Pharma A/S ADR (ASND)
Ascendis Pharma A/S ADR (NASDAQ: ASND) saw its 5-day average volume 1.01 million, a positive change from its year-to-date volume of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 73.75%.
During the past 100 days, Ascendis Pharma A/S ADR’s (ASND) raw stochastic average was set at 89.37%, which indicates a significant increase from 81.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 9.62 in the past 14 days, which was higher than the 7.22 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $202.09, while its 200-day Moving Average is $174.69. Nevertheless, the first resistance level for the watch stands at $225.66 in the near term. At $234.77, the stock is likely to face the second major resistance level. The third major resistance level sits at $246.35. If the price goes on to break the first support level at $204.98, it is likely to go to the next support level at $193.40. The third support level lies at $184.29 if the price breaches the second support level.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Key Stats
The company with the Market Capitalisation of 13.23 billion has total of 61,695K Shares Outstanding. Its annual sales at the moment are 393,500 K in contrast with the sum of -409,120 K annual income. Company’s last quarter sales were recorded 179,410 K and last quarter income was -44,110 K.
